Provider Antibody Serology Study of Virus in the Emergency Room (PASSOVER) Study: Special Population COVID-19 Seroprevalence
Introduction: Limited data on the seroprevalence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) among healthcare workers (HCW) are publicly available. In this study we sought to determine the seroprevalence of SARS-CoV-2 in a population of HCWs in a pediatric emergency department (E...
Main Authors: | , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
eScholarship Publishing, University of California
2021-05-01
|
Series: | Western Journal of Emergency Medicine |
Online Access: | https://escholarship.org/uc/item/4rv6721f |
_version_ | 1818743574482649088 |
---|---|
author | Theodore W. Heyming Terence Sanger Aprille Tongol John Schomberg Kellie Bacon Bryan Lara |
author_facet | Theodore W. Heyming Terence Sanger Aprille Tongol John Schomberg Kellie Bacon Bryan Lara |
author_sort | Theodore W. Heyming |
collection | DOAJ |
description | Introduction: Limited data on the seroprevalence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) among healthcare workers (HCW) are publicly available. In this study we sought to determine the seroprevalence of SARS-CoV-2 in a population of HCWs in a pediatric emergency department (ED). Methods: We conducted this observational cohort study from April 14–May 13, 2020 in a pediatric ED in Orange County, CA. Asymptomatic HCW ≥18 years of age were included in the study. Blood samples were obtained by fingerstick at the start of each shift. The inter-sampling interval was ≤96 hours. The primary outcome was positive seroprevalence of SARS-CoV-2 as determined with an antibody fast detection kit (Colloidal Gold, Superbio, Timisoara, Romania) for the SARS-CoV-2 immunoglobulin M/immunoglobulin G (IgM/IgG) antibody. Results: A total of 143 HCWs participated in the study. Overall SARS-CoV-2 seroprevalence was 10.5% (n = 15). Positive seroprevalence was classified as IgG only (4.9%), IgM+IgG (3.5%), or IgM only (2.1%). SARS-CoV-2 was detected by reverse transcription polymerase chain reaction RT-PCR in 0.7% of the overall study population (n = 1). Samples obtained on Day 1 indicated seropositivity in 4.2% of the study population (n = 6). Subsequent seroconversion occurred in 6.3% of participants (n = 9). The rate of seroconversion was linear with a rate of approximately one new case every two days, starting at Day 9 of the study. Conclusion: We observed a linear rate of seroconversion to SARS-CoV-2–positive status among asymptomatic HCWs who underwent daily symptom surveys and temperature screens in an environment with universal source control. Rapid antibody testing may be useful for screening for SARS-CoV-2 seropositivity in high-risk populations, such as HCWs in the ED. |
first_indexed | 2024-12-18T02:30:35Z |
format | Article |
id | doaj.art-7db54fa2116d4cdb9c00ca18d21b5420 |
institution | Directory Open Access Journal |
issn | 1936-9018 |
language | English |
last_indexed | 2024-12-18T02:30:35Z |
publishDate | 2021-05-01 |
publisher | eScholarship Publishing, University of California |
record_format | Article |
series | Western Journal of Emergency Medicine |
spelling | doaj.art-7db54fa2116d4cdb9c00ca18d21b54202022-12-21T21:23:55ZengeScholarship Publishing, University of CaliforniaWestern Journal of Emergency Medicine1936-90182021-05-0122310.5811/westjem.2021.1.50058wjem-22-565Provider Antibody Serology Study of Virus in the Emergency Room (PASSOVER) Study: Special Population COVID-19 SeroprevalenceTheodore W. Heyming0Terence Sanger1Aprille Tongol2John Schomberg3Kellie Bacon4Bryan Lara5Children’s Hospital of Orange County, Department of Emergency Medicine, Orange, CaliforniaUniversity of California, Irvine, Department of Electrical Engineering and Computer Science, Irvine, CaliforniaChildren’s Hospital of Orange County, Research Institute, Orange, CaliforniaChildren’s Hospital of Orange County, Department of Nursing, Orange, CaliforniaChildren’s Hospital of Orange County, Research Institute, Orange, CaliforniaChildren’s Hospital of Orange County, Research Institute, Orange, CaliforniaIntroduction: Limited data on the seroprevalence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) among healthcare workers (HCW) are publicly available. In this study we sought to determine the seroprevalence of SARS-CoV-2 in a population of HCWs in a pediatric emergency department (ED). Methods: We conducted this observational cohort study from April 14–May 13, 2020 in a pediatric ED in Orange County, CA. Asymptomatic HCW ≥18 years of age were included in the study. Blood samples were obtained by fingerstick at the start of each shift. The inter-sampling interval was ≤96 hours. The primary outcome was positive seroprevalence of SARS-CoV-2 as determined with an antibody fast detection kit (Colloidal Gold, Superbio, Timisoara, Romania) for the SARS-CoV-2 immunoglobulin M/immunoglobulin G (IgM/IgG) antibody. Results: A total of 143 HCWs participated in the study. Overall SARS-CoV-2 seroprevalence was 10.5% (n = 15). Positive seroprevalence was classified as IgG only (4.9%), IgM+IgG (3.5%), or IgM only (2.1%). SARS-CoV-2 was detected by reverse transcription polymerase chain reaction RT-PCR in 0.7% of the overall study population (n = 1). Samples obtained on Day 1 indicated seropositivity in 4.2% of the study population (n = 6). Subsequent seroconversion occurred in 6.3% of participants (n = 9). The rate of seroconversion was linear with a rate of approximately one new case every two days, starting at Day 9 of the study. Conclusion: We observed a linear rate of seroconversion to SARS-CoV-2–positive status among asymptomatic HCWs who underwent daily symptom surveys and temperature screens in an environment with universal source control. Rapid antibody testing may be useful for screening for SARS-CoV-2 seropositivity in high-risk populations, such as HCWs in the ED.https://escholarship.org/uc/item/4rv6721f |
spellingShingle | Theodore W. Heyming Terence Sanger Aprille Tongol John Schomberg Kellie Bacon Bryan Lara Provider Antibody Serology Study of Virus in the Emergency Room (PASSOVER) Study: Special Population COVID-19 Seroprevalence Western Journal of Emergency Medicine |
title | Provider Antibody Serology Study of Virus in the Emergency Room (PASSOVER) Study: Special Population COVID-19 Seroprevalence |
title_full | Provider Antibody Serology Study of Virus in the Emergency Room (PASSOVER) Study: Special Population COVID-19 Seroprevalence |
title_fullStr | Provider Antibody Serology Study of Virus in the Emergency Room (PASSOVER) Study: Special Population COVID-19 Seroprevalence |
title_full_unstemmed | Provider Antibody Serology Study of Virus in the Emergency Room (PASSOVER) Study: Special Population COVID-19 Seroprevalence |
title_short | Provider Antibody Serology Study of Virus in the Emergency Room (PASSOVER) Study: Special Population COVID-19 Seroprevalence |
title_sort | provider antibody serology study of virus in the emergency room passover study special population covid 19 seroprevalence |
url | https://escholarship.org/uc/item/4rv6721f |
work_keys_str_mv | AT theodorewheyming providerantibodyserologystudyofvirusintheemergencyroompassoverstudyspecialpopulationcovid19seroprevalence AT terencesanger providerantibodyserologystudyofvirusintheemergencyroompassoverstudyspecialpopulationcovid19seroprevalence AT aprilletongol providerantibodyserologystudyofvirusintheemergencyroompassoverstudyspecialpopulationcovid19seroprevalence AT johnschomberg providerantibodyserologystudyofvirusintheemergencyroompassoverstudyspecialpopulationcovid19seroprevalence AT kelliebacon providerantibodyserologystudyofvirusintheemergencyroompassoverstudyspecialpopulationcovid19seroprevalence AT bryanlara providerantibodyserologystudyofvirusintheemergencyroompassoverstudyspecialpopulationcovid19seroprevalence |